UNCY
Unicycive Therapeutics Inc
4.20$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -1,645.7% | -2,708.6% | – | – | |
| – | – | – | – | 16.9% | 42.1% | – | – | |
| – | – | – | – | 110.1% | 261.8% | – | – | |
| – | – | – | – | 123.9% | -13.8% | – | – | |
| – | – | – | – | 0.2% | 1.8% | – | – | |
| – | – | – | – | -0.2% | -1.8% | – | – | |
| – | – | – | – | – | 128.4% | – | – | |
| – | – | – | – | 0.0% | – | – | – | |
| – | – | – | – | -49.5% | 4,080.1% | – | – | |
| – | – | – | – | -1,695.5% | 1,369.8% | – | – | |
| – | – | – | – | -1,646.0% | -2,710.4% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.